Rodgers, Mark; Griffin, Susan; Paulden, Mike; Slack, Russell - In: PharmacoEconomics 28 (2010) 5, pp. 351-362
Pharmaceuticals Ltd, Basel, Switzerland) to submit evidence for the clinical and cost effectiveness of this drug for the treatment of … NICE's subsequent decisions. The ERG produced a critical review of the evidence for the clinical and cost effectiveness of …'s original submission to NICE, the base-case incremental cost-effectiveness ratios (ICERs) reported for alitretinoin were £8614 …